產(chǎn)品中心
紅色安全頭蓋指示此類(lèi)采血管在試管內(nèi)沒(méi)有添加任何添加劑，用于血清生化，血庫(kù)和血清學(xué)相關(guān)檢驗(yàn)。Orsin真空采血管進(jìn)行了特殊工藝處理，無(wú)論是玻璃管還是塑料管，其內(nèi)壁能有效避免血細(xì)胞附壁，******限度減少標(biāo)本體外溶血。使檢測(cè)結(jié)果更加準(zhǔn)確。
塑料試管
玻璃試管
黑頭管采用 0.129mol/L 檸 檬酸鈉緩沖體系對(duì)血液標(biāo)本進(jìn)行抗凝 , 用于“魏氏沉 降法”進(jìn)行血液沉降速率檢測(cè)?？鼓齽┡c血液的體積比為 1:4 。包括提供直接標(biāo)本的動(dòng)態(tài)血沉管和需要標(biāo)本轉(zhuǎn)裝的 75mm 短管。動(dòng)態(tài)血沉管可在采血后直接上架讀數(shù)或應(yīng)用于動(dòng)態(tài)血沉儀。 Black cap tubes, with 0.129mol/L sodium citrate buffer systems to carry out anticoagulation on blood specimen, are used for the testing blood sedimentation rate by Westergern method. The volume ratio between anticoagulant and blood is 1:4. They cover the dynamic blood sedimentation tube directly offering specimen and 75mm short tubes needing specimen transfer. Dynamic blood sedimentation tube may read directly on the frame after blood collection, or be used in blood sedimentation unit
紫頭管中的抗凝劑為 EDTA 鹽。國(guó)際血液委員會(huì)推薦使用抗凝效率較高 , 穩(wěn)定性更強(qiáng) , ph 值與血液相對(duì)接近的乙二胺四乙酸 · 二鉀(EDTA.K2)。 獨(dú)一無(wú)二的內(nèi)壁仿生活性膜處理 , 有效地維持了血小板的活性穩(wěn)定。微噴霧技術(shù)的運(yùn)用降低 了因血小板黏附與聚集而發(fā)生血小板損失和凝血的風(fēng)險(xiǎn) ,嚴(yán)格的微粒污染控制工藝杜絕了微粒污染對(duì)檢驗(yàn)結(jié)果的影響。 Purple cap use EDTA salt as anticoagulant. ICSH recommends using EDTA.K2, which is with higher anticoagulation efficiency, stronger stability and relatively closer ph value with blood. The unique imitated life film treatment on its inner wall can effectively maintain the active stability of platelet. The application of micro atomizing technology has lowered the hazard of platelet loss and blood coagulation caused by platelet adherence and gathering. And the rigorous particle pollution control technology has completely eradicated the impact on test result caused by particle pollution.
通常由拭子和/或含保存液的杯、管等組成。非無(wú)菌提供。用于樣本的收集、運(yùn)輸和儲(chǔ)存等。
通常由拭子和/或含保存液的杯、管等組成。非無(wú)菌提供。 用于樣本的收集、運(yùn)輸和儲(chǔ)存等。
灰頭管摒棄了傳統(tǒng)的草酸鉀 - 氟化鈉抗凝體系 , 創(chuàng)造性地采用了全 球技術(shù)領(lǐng)先的復(fù)合抗凝體系 , 在保持傳統(tǒng)灰頭管抑制糖代謝 , 防止糖降 解的功能同時(shí) , 避免了外源性凝血及溶血的風(fēng)險(xiǎn) , 實(shí)現(xiàn)了血糖標(biāo)本的長(zhǎng) 期穩(wěn)定。 Grey cap tubes have abandoned the conventional potassium oxalate-NaF anticoagulation system and have creatively adopted the globally leading com-posite anticoagulation system. While having maintained the functions of inhibit glycometab-olism and prevent glucose degradation of conventional grey cap tubes, they have avoided the risk of extrinsic blood coagulation and hemolytic, so as to ensure the long-time stability of blood glucose specimen.
綠色安全頭蓋指示此類(lèi)采血管中添加了以鈉鹽或鋰鹽型式存在的肝素抗凝劑。先進(jìn)的微噴霧技術(shù)確保肝素抗凝劑迅速作用于血液標(biāo)本 , 為臨床實(shí)驗(yàn)提供立等可取的血漿標(biāo)本 , 因而多用作急診生化實(shí)驗(yàn) , 同時(shí) , 因肝素抗凝標(biāo)本的血液流變學(xué)性質(zhì)差別不大 , 故又常用于血液流變學(xué)實(shí)驗(yàn)。 Green cap indicate that there is heparin anticoagulant of sodium or lithium salt; with advanced micro atomizing technology to ensure heparin anticoagulant quickly acting in blood specimen, which provide clinical laboratory with immediate plasma specimen, therefore it is always used in emergency biochemical laboratory. In the meanwhile,due to small difference in the hem rheological changes nature of anticoagulant of heparin specimen, it is often used in hem rheological laboratory.
掃描關(guān)注 
